Nippon India Nifty Pharma Etf Overview
Category Other ETFs
BMSMONEY Rank 8
BMSMONEY Rating
Gro. Opt. As On: 19-11-2024
NAV ₹22.19(R) +1.04% (D) %
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 38.22% 17.95% -% -% -%
LumpSum (D)
SIP (R) 8.31% 26.6% -% -% -%
SIP (D)
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.65 0.37 0.68 -% -
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.25% -18.01% -16.65% - 10.9%
Top Other ETFs
Fund Name Rank Rating
cpse etf 1
bharat 22 etf 2
Aditya Birla Sun Life Nifty Healthcare ETF 3
ICICI Prudential Nifty Healthcare ETF 4
Nippon India ETF Nifty Dividend Opportunities 50 5
Axis NIFTY Healthcare ETF 6
Nippon India Etf Nifty Midcap 150 7
Nippon India Nifty Pharma ETF 8
Motilal Oswal Nifty Midcap 100 ETF 9
Icici Prudential Nifty Next 50 Etf 10
Uti Nifty Next 50 Exchange Traded Fund 11
UTI BSE Sensex Next 50 Exchange Traded Fund 12
ICICI Prudential Nifty India Consumption ETF 13
Nippon India ETF BSE Sensex Next 50 14
SBI Nifty Next 50 ETF 15
SBI BSE Sensex Next 50 ETF 16
kotak nifty 50 value 20 etf 17

NAV Date: 19-11-2024

Scheme Name NAV Rupee Change Percent Change
Nippon India Nifty Pharma ETF 22.19
0.2300
1.0400%

Review Date: 19-11-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It denotes the rise in the investment's worth during the investment period, expressed as a percentage or a monetary value. As part of our analysis, we evaluated five return parameters of this fund. We have classified the return parameters into three performance groups: the top 25%, parameters that fall below the top 25% but remain above average, and parameters that are below average. The performance of each parameter is outlined below.
    1. Top 25%: The Nippon India Nifty Pharma ETF has three return parameters in the top 25% in the category, as shown below:
      • 6M Return %
      • 1Y Return %
      • 3Y Return %
    2. Above Average Below the Top 25%: The Nippon India Nifty Pharma ETF has one return parameter in the category, which is above average but below the top 25%, as shown below:
      • 3M Return %
    3. Below Average: One return parameter of the fund is below average in the category, which is listed below:
      • 1M Return %
  2. Risk: It is defined as the prospect of not attaining expected yields or enduring financial setbacks due to numerous causes. For Nippon India Nifty Pharma ETF, we have analyzed two risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Nippon India Nifty Pharma ETF does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Nippon India Nifty Pharma ETF does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: Nippon India Nifty Pharma ETF has two parameters that are above average which are listed below:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 16.25 %.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.9 %.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated three risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: Nippon India Nifty Pharma ETF has three risk-adjusted performance parameters of the fund that are in the this group of the category.
      • Sharpe Ratio: Nippon India Nifty Pharma ETF has a Sharpe Ratio of 0.65 compared to the category average of 0.36.
      • Sterling Ratio: Nippon India Nifty Pharma ETF has a Sterling Ratio of 0.68 compared to the category average of 0.59.
      • Sortino Ratio: Nippon India Nifty Pharma ETF has a Sortino Ratio of 0.37 compared to the category average of 0.17.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -5.85
-4.13
-9.06 | 5.67 124 | 186 Average
3M Return % -2.17
-2.35
-14.26 | 25.71 71 | 186 Good
6M Return % 13.64
4.92
-10.18 | 26.60 19 | 178 Very Good
1Y Return % 38.22
15.71
-89.10 | 54.69 16 | 166 Very Good
3Y Return % 17.95
2.36
-50.39 | 43.66 12 | 100 Very Good
1Y SIP Return % 8.31
-6.01
-39.83 | 26.22 9 | 154 Very Good
3Y SIP Return % 26.60
15.24
-11.92 | 46.84 11 | 90 Very Good
Standard Deviation 16.25
13.85
0.00 | 28.97 58 | 80 Average
Semi Deviation 10.90
9.61
0.00 | 18.80 48 | 80 Average
Max Drawdown % -16.65
-12.90
-38.86 | 0.00 67 | 80 Poor
VaR 1 Y % -18.01
-16.92
-34.01 | 0.00 47 | 80 Average
Average Drawdown % -5.54
-5.78
-19.01 | 0.00 41 | 80 Average
Sharpe Ratio 0.65
0.36
-0.74 | 1.89 21 | 77 Good
Sterling Ratio 0.68
0.59
-0.01 | 2.15 26 | 80 Good
Sortino Ratio 0.37
0.17
-1.00 | 1.16 21 | 80 Good
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 16.25 13.85 0.00 | 28.97 58 | 80
Semi Deviation 10.90 9.61 0.00 | 18.80 48 | 80
Max Drawdown % -16.65 -12.90 -38.86 | 0.00 67 | 80
VaR 1 Y % -18.01 -16.92 -34.01 | 0.00 47 | 80
Average Drawdown % -5.54 -5.78 -19.01 | 0.00 41 | 80
Sharpe Ratio 0.65 0.36 -0.74 | 1.89 21 | 77
Sterling Ratio 0.68 0.59 -0.01 | 2.15 26 | 80
Sortino Ratio 0.37 0.17 -1.00 | 1.16 21 | 80
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 1.04 ₹ 10,104.00 ₹
1W -1.73 ₹ 9,827.00 ₹
1M -5.85 ₹ 9,415.00 ₹
3M -2.17 ₹ 9,783.00 ₹
6M 13.64 ₹ 11,364.00 ₹
1Y 38.22 ₹ 13,822.00 ₹
3Y 17.95 ₹ 16,409.00 ₹
5Y ₹ ₹
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 8.31 ₹ 12,535.39 ₹
3Y ₹ 36000 26.60 ₹ 52,903.73 ₹
5Y ₹ 60000 ₹ ₹
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Nippon India Nifty Pharma Etf NAV Regular Growth Nippon India Nifty Pharma Etf NAV Direct Growth
19-11-2024 22.1901 None
18-11-2024 21.9613 None
14-11-2024 22.1735 None
13-11-2024 22.232 None
12-11-2024 22.5809 None
11-11-2024 22.7773 None
08-11-2024 22.9794 None
07-11-2024 22.9639 None
06-11-2024 23.3649 None
05-11-2024 23.0971 None
04-11-2024 23.0739 None
31-10-2024 23.1735 None
30-10-2024 22.8062 None
29-10-2024 23.0372 None
28-10-2024 23.2981 None
25-10-2024 23.0104 None
24-10-2024 23.0067 None
23-10-2024 22.9057 None
22-10-2024 23.2693 None
21-10-2024 23.5696 None

Fund Launch Date: 02/Jul/2021
Fund Category: Other ETFs
Investment Objective: The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Fund Description: An open ended scheme replicating/ tracking NIFTY Pharma Index
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.